Netosis - OmicsDI

Show results for

Unknown (666)
Genomics (70)
Transcriptomics (51)
Proteomics (37)
Other (3)
Metabolomics (2)
Clinical (1)

Organisms

Mus musculus (35)
Homo sapiens (29)
Schizophyllum commune H4-8 (23)
Mycobacterium tuberculosis SP7 (23)
Oryza sativa Japonica Group (23)
Crotalus durissus terrificus (23)
Eriocheir sinensis (23)
Candidatus Endoriftia persephonae (23)
Mycobacterium tuberculosis SP10 (23)
Mycobacterium tuberculosis SP13 (23)
Cotesia typhae (23)
Mycobacterium tuberculosis SP22 (23)
Cepaea nemoralis (23)
Enterobacter ludwigii (23)
Trichoderma asperellum CBS 433.97 (23)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (23)
Nakaseomyces glabratus (23)
Olea europaea (23)
Chlamydomonas reinhardtii (23)
Lama (23)
Planorbella pilsbryi (23)
Wolbachia sp. wMelPop (23)
Pyricularia oryzae P131 (23)
Macaca mulatta (2)
Bos taurus (2)
Oryctolagus cuniculus (1)
Gallus gallus (1)
Escherichia coli (1)
Rattus norvegicus (1)
Mus (1)

Organisms

Mus musculus (33)
Homo sapiens (18)
Macaca mulatta (2)
Mus (1)
Rattus norvegicus (1)
Bos taurus (1)

Repository

ENA (65)
geo (57)
pride (23)
MassIVE (6)
biostudies-arrayexpress (4)
iProX (4)
EGA (2)
MetaboLights (2)

Tissue

Neutrophil (8)
Blood (4)
Cell culture (2)
Rheumatoid arthritis disease specific synovial fluid (1)
Tear (1)
Milk (1)
Macrophage (1)
Cell line cell (1)
Primary cell (1)
Lung (1)
Blood cell (1)
Colon (1)

Disease

Non-diabetic (1)
Colorectal cancer (1)
Type 1 diabetes mellitus (1)
COVID-19 (1)
Rheumatoid arthritis (1)
Disease free (1)
Gray platelet syndrome (1)

Technology Type

Mass Spectrometry (23)
Shotgun proteomics (15)
Bottom-up proteomics (6)
Mass spectrometry (2)
All-ion fragmentation (1)
Gel-based experiment (1)
Data-dependent acquisition (1)

Instrument Platform

Orbitrap Fusion (2)
TimsTOF Pro (1)
Orbitrap Exploris 480 (1)
Q Exactive HF-X (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (20)
2026 (17)
2021 (12)
2024 (11)
2023 (9)
2022 (8)
2012 (4)
2019 (3)
2018 (3)
2011 (2)
2020 (2)
2016 (2)
2010 (1)

CHEBI ID

CHEBI:174850 (2)
CHEBI:46659 (2)
CHEBI:34690 (2)
CHEBI:27402 (2)
CHEBI:9093 (2)
CHEBI:10444 (2)
CHEBI:3746 (2)
CHEBI:3219 (2)
CHEBI:2453 (2)
CHEBI:177282 (2)
CHEBI:168124 (2)
CHEBI:7856 (2)
CHEBI:27827 (2)
CHEBI:17401 (2)
CHEBI:10049 (2)
CHEBI:36491 (2)
CHEBI:27701 (2)
CHEBI:8497 (2)
CHEBI:28283 (2)
CHEBI:10082 (2)
CHEBI:80127 (2)
CHEBI:16871 (2)
CHEBI:9342 (2)
CHEBI:7494 (2)
CHEBI:3077 (2)
CHEBI:45980 (2)
CHEBI:5557 (2)
CHEBI:31648 (2)
CHEBI:27836 (2)
CHEBI:16587 (2)

Metabolite Name

Laurylaldehyde (2)
(S)-3-Hydroxyhexadecanoyl-CoA (2)
Undecan-2-one (2)
Clindamycin phosphate (2)
Bupropion (2)
Ipratropium bromide (2)
Myo-inositol hexakisphosphate (2)
Cyanidin 3-glucoside (2)
Sinensal (2)
Prenol (2)
Selenocysteine (2)
Aciclovir (2)
Ibutilide (2)
Palmitaldehyde (2)
2-Methoxy-estradiol-17b 3-glucuronide (2)
Agmatine (2)
Guanethidine (2)
Angiotensin IV (2)
5-Methyltetrahydrofolic acid (2)
Sulindac (2)
Haloperidol (2)
Butanal (2)
Xanthosine 5-triphosphate (2)
Beta-D-3-Ribofuranosyluric acid (2)
Phytol (2)
Thiamine monophosphate (2)
Pentadecanal (2)
Cysteic acid (2)
Cyclic GMP (2)
Nicardipine (2)

First Public Date

2026 (16)
2025 (15)
2024 (10)
2022 (6)
2021 (6)
2023 (5)
2014 (3)
2020 (2)
2019 (1)
2017 (1)

Study status

Recruiting (1)

Study type

Transcription profiling by array (2)
Proteomic profiling by array (2)
Interventional (1)

Release Date

2025 (105)
2022 (92)
2021 (86)
2023 (77)
2024 (75)
2020 (56)
2019 (48)
2018 (32)
2017 (26)
2026 (22)
2016 (19)
2015 (10)
2012 (6)
2014 (6)
2013 (5)
2011 (3)
2010 (1)
2009 (1)

Lab affiliation

Centre for Ocular Regeneration (CORE), Prof. Brien Holden Eye Research Centre (BHERC), L V Prasad Eye Institute, Hyderabad, Telangana, India (2)
Life Sciences Institute, University of Michigan; Ann Arbor 48109, USA. (1)
Deparment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea1Deparment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea (1)
Uni Greifswald Hausdorffstrasse 8 17489 Greifswald Germany; Institute for Microbiology; Department of Microbial Proteomics (1)
laboratory for Medical Massspectrometry, Aalborg University, Denmark (1)
Universität Greifswald Hausdorffstrasse 8 17489 Greifswald Germany (1)
The Laboratory for Molecular Pathways in the Resolution of Inflammation, The Departments of Biology and Human Biology, University of Haifa, Israel (1)
Department of Chemistry, Stanford University Stanford ChEM-H (1)
Max Planck Unit for the Science of Pathogens Charitéplatz 1, D-10117 Berlin, Germany (1)
Department of Medecine, Service of Pneumology, Université de Sherbrooke (1)
IRCCS G. Gaslini, Core Facilities - Clinical Proteomics and Metabolomics, Genoa, Italy (1)
Laboratory of Proteomics, Department of Molecular Hematology, Sanquin Research, Amsterdam, NL (1)
Director-Research, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India (1)
Molecular Virology and Microbiology Alkek Center for Metagenomics and Microbiome Research Baylor College of Medicine Houston, Texas United States (1)
Max Planck Unit for the Science of Pathogens, Berlin, Germany (1)
Professor Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN USA (1)
Clinical and Experimental Endocrinology Department, KU Leuven, Leuven, Belgium (1)
Department of Gastroenterology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China (1)
University of Greifswald, Institute of Microbiology, Department of Microbial Proteomics, Greifswald, Germany (1)
Babraham Institute (1)
IRCCS Istituto G Gaslini (1)
Ist. G. Gaslini (1)

Location

China (1)

Previous page
1 / 83
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 83
Next page

Sort by:

Relevance

Page size

Tamm-Horsfall protein augments neutrophil NETosis

Proteome profiles of isolated peripheral human neutrophils pretreated with purified Tamm-Horsfall protein and stimulated to undergo NETosis with PMA.

ORGANISM(S): Homo sapiens (Human)

2024-09-23 | PXD045468 | Pride

Phospho-proteomic Analyses Provide Insight into Underlying Molecular Mechanisms of NETosis

NETosis, a novel cell death leads to neutrophil extracellular trap (NET) formation, is involved in both infectious and noninfectious disease. However, mechanisms underlying NETosis remain unclear. To explore the underlying molecular mechanisms and common factors associated with both NOX-dependent an...

ORGANISM(S): Homo Sapiens

2019-06-27 | PXD014418 |

Regulating NETosis: Increasing pH Promotes NADPH Oxidase-Dependent NETosis.

Not available

S-EPMC5816902 | biostudies-literature

Inhibition of netosis with PAD inhibitor attenuates endotoxin shock induced systemic inflammation

PRJNA839858 | ENA

Inhibition of NETosis via PAD4 could alleviate the inflammation of giant cell myocarditis

PRJNA912772 | ENA

NETosis in pulmonary pleomorphic carcinoma.

Not available

S-EPMC11786310 | biostudies-literature

Transcriptional firing helps to drive NETosis.

Not available

S-EPMC5296899 | biostudies-literature

Machine Learning to Quantitate Neutrophil NETosis.

Not available

S-EPMC6858304 | biostudies-literature

CONNETTING ANTI-2GLYCOPROTEIN I ANTIBODIES, NETosis AND ENDOTHELIAL CELL ACTIVATION

This project aims to explore the intricate relationship between anti-β2glycoprotein I (aβ2GPI) antibodies, neutrophil extracellular traps (NETs), and endothelial cell activation in Antiphospholipid Syndrome (APS), an autoimmune disorder characterized by thrombotic events. This study tested the hypot...

ORGANISM(S): Homo sapiens (Human)

2025-08-25 | PXD052010 | Pride

Netosis Autoimmune disorder Antiphospholipid syndrome Endothelial cell activation

Molecular mechanisms and therapeutic target of NETosis in diseases.

Not available

S-EPMC9390875 | biostudies-literature

Previous page
1 / 83
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 83
Next page

Sort by:

Relevance

Page size

830 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets